iOncologi, Inc. Acquires TargImmune Therapeutics To Expand and Strengthen Immunotherapy Pipeline Against Solid Tumors
UF startup iOncologi announced the acquisition of TargImmune Therapeutics to enhance its capabilities in developing immunotherapies for solid tumors.
UF Researchers Demonstrate GLP-1RAs’ Potential To Treat Depression
UF researchers have found that GLP-1RAs, a class of glucose-lowering medications, may have antidepressant effects in a study funded by the NIH.
Mutations Disrupt Touch-Based Learning, Study Finds
UF researchers, supported by the National Institutes of Health, have found that the Syngap1 gene plays a crucial role in touch-based perception, while certain mutations can lead to mixed signals.
UF Ranked Among World’s Top Universities in Number of Patents
The National Academy of Inventors ranked the University of Florida No. 20 on the list of Top 100 Worldwide Universities Granted Utility Patents in 2024.
University of Florida Studies Use of Eye Tracking Technology With Public Transit Drivers
In this week’s Tech Tuesday, UF Innovate's host Bethany Gaffey introduces Bryce Grame, a UF Ph.D. student, who, along with his team at the UF Transportation Institute, conducted a study using eye-tracking technology to enhance safety and training for transit drivers in public transportation.
Eat Better, Breathe Easier? Research Points To Link Between Diet, Lung Cancer
UF researchers have found that poor diet may influence lung cancer risk, challenging traditional views on diet-related diseases.
Atsena Therapeutics Granted U.S. FDA Fast Track Designation for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
UF Team Develops AI Tool To Make Genetic Research More Comprehensive
UF researchers developed PhyloFrame, a machine-learning tool that leverages artificial intelligence to account for ancestral diversity in genetic data, addressing a critical gap in medical genetic research.
Oragenics, Inc. Submits Investigator’s Brochure for Phase II Clinical Trial of ONP-002 in Mild Traumatic Brain Injury
UF Innovate | Accelerate graduate Oragenics, Inc. announced the submission of its Investigator’s Brochure (IB) application in preparation for its Phase II clinical trial using ONP-002 in Australia.
University of Florida Professor Explores Ways To Defend Against Deepfakes and Digital Scams
In this week’s Tech Tuesday, UF Innovate's host Bethany Gaffey meets Dr. Patrick Traynor, a professor in the Computer and Information Science and Engineering (CISE) department at the University of Florida.
